دورية أكاديمية

From intuition to AI: evolution of small molecule representations in drug discovery.

التفاصيل البيبلوغرافية
العنوان: From intuition to AI: evolution of small molecule representations in drug discovery.
المؤلفون: McGibbon, Miles1 (AUTHOR), Shave, Steven1 (AUTHOR), Dong, Jie2 (AUTHOR), Gao, Yumiao1 (AUTHOR), Houston, Douglas R1 (AUTHOR), Xie, Jiancong3 (AUTHOR), Yang, Yuedong3 (AUTHOR), Schwaller, Philippe4 (AUTHOR), Blay, Vincent1 (AUTHOR) v1vblay@ed.ac.uk
المصدر: Briefings in Bioinformatics. Jan2024, Vol. 25 Issue 1, p1-13. 13p.
مصطلحات موضوعية: *ARTIFICIAL intelligence, DRUG discovery, SMALL molecules, HUMAN fingerprints, INTUITION, MACHINE learning
مستخلص: Within drug discovery, the goal of AI scientists and cheminformaticians is to help identify molecular starting points that will develop into safe and efficacious drugs while reducing costs, time and failure rates. To achieve this goal, it is crucial to represent molecules in a digital format that makes them machine-readable and facilitates the accurate prediction of properties that drive decision-making. Over the years, molecular representations have evolved from intuitive and human-readable formats to bespoke numerical descriptors and fingerprints, and now to learned representations that capture patterns and salient features across vast chemical spaces. Among these, sequence-based and graph-based representations of small molecules have become highly popular. However, each approach has strengths and weaknesses across dimensions such as generality, computational cost, inversibility for generative applications and interpretability, which can be critical in informing practitioners' decisions. As the drug discovery landscape evolves, opportunities for innovation continue to emerge. These include the creation of molecular representations for high-value, low-data regimes, the distillation of broader biological and chemical knowledge into novel learned representations and the modeling of up-and-coming therapeutic modalities. [ABSTRACT FROM AUTHOR]
Copyright of Briefings in Bioinformatics is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Business Source Index
الوصف
تدمد:14675463
DOI:10.1093/bib/bbad422